Costs of HIV+/AIDS at CD4+ counts disease stages based on treatment protocols

• Published in: Journal of acquired immune deficiency syndromes and human retrovirology Vol. 12; no. 4; p. 413
• Main Authors: Gable, C B, Tierce, J C, Simison, D, Ward, D, Motte, K
• Format: Journal Article
• Language: English
• Published: United States 01.08.1996
• Subjects: Acquired Immunodeficiency Syndrome - economics; Acquired Immunodeficiency Syndrome - immunology; Acquired Immunodeficiency Syndrome - therapy; AIDS-Related Opportunistic Infections - economics; AIDS-Related Opportunistic Infections - therapy; CD4 Lymphocyte Count; Cost of Illness; Delivery of Health Care - economics; Disease Progression; Health Resources - utilization; HIV Seropositivity - economics; HIV Seropositivity - immunology; HIV Seropositivity - therapy; Hospitalization - economics; Humans; Sensitivity and Specificity; United States; United States

We report treatment protocols for HIV+/AIDS patients by CD4+ counts (T-lymphocyte cells/mm3: > or = 500, 499-200, 199-50, and < 50) as a tool to provide better definition and to project annual costs (total charges for services) and lifetimes costs for HIV+/AIDS. The treatment protocols, derive...